Advancements in immunotherapy for glomerulonephritis: promising treatments on the horizon
Madam, Over the years, glomerulonephritis management has been predominantly reliant on corticosteroids and immunosuppressive agents. However, emerging research on targeted immunotherapies, such as biologics and monoclonal antibodies, has shown remarkable potential in halting the disease progressi...
Wedi'i Gadw mewn:
| Prif Awduron: | , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Pakistan Medical Association
2024-04-01
|
| Cyfres: | Journal of the Pakistan Medical Association |
| Pynciau: | |
| Mynediad Ar-lein: | https://jpma.org.pk/index.php/public_html/article/view/10666 |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|